Simon Suk Yeon Kim - Publications

Affiliations: 
2005 Yale University, New Haven, CT 

37 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Schaufler C, Kaul S, Fleishman A, Korets R, Chang P, Wagner A, Kim S, Bellmunt J, Kaplan I, Olumi AF, Gershman B. Immediate radiotherapy versus observation in patients with node-positive prostate cancer after radical prostatectomy. Prostate Cancer and Prostatic Diseases. PMID 36434164 DOI: 10.1038/s41391-022-00619-1  0.327
2020 Reitblat C, Fleishman A, Kaplan I, Stensland K, DʼAmico A, Olumi A, Wagner A, Chang P, Kim S, Korets R, Gershman B. Pd63-05 Emulating A Clinical Trial Of Radical Prostatectomy Versus External Beam Radiation Therapy For High-Grade, Clinically Localized Prostate Cancer The Journal of Urology. 203. DOI: 10.1097/Ju.0000000000000980.05  0.361
2020 Unadkat P, Fleishman A, Olumi A, Wagner A, Chang P, Kim S, Korets R, Gershman B. Mp76-13 Examining The Survival Benefit Of Inguinal Lymph Node Dissection In Men With Cn0 Penile Cancer The Journal of Urology. 203. DOI: 10.1097/Ju.0000000000000962.013  0.318
2020 Bidikov L, Maroni P, Pugh T, Kukreja J, Nath S, Pessoa R, Kim S. Mp27-14 A National Survey Of Radiation Oncologists And Urologists On Proton Beam Radiotherapy And Robotic Surgery For Localized Prostate Cancer The Journal of Urology. 203. DOI: 10.1097/Ju.0000000000000866.014  0.341
2019 Owens OL, Kim S, Tavakoli AS. Are decision aids leading to shared prostate cancer screening decisions among African-American men?: iDecide. Cancer Causes & Control : Ccc. PMID 31093861 DOI: 10.1007/S10552-019-01179-X  0.331
2019 Owens OL, Estrada RM, Johnson K, Cogdell M, Fried DB, Gansauer L, Kim S. 'I'm not a chance taker': A mixed methods exploration of factors affecting prostate cancer treatment decision-making. Ethnicity & Health. 1-20. PMID 30987436 DOI: 10.1080/13557858.2019.1606165  0.388
2019 Gershman B, Maroni P, Tilburt J, Volk R, Konety B, Kutikov A, Smaldone M, Chen V, Kim S. Mp44-17 A National Survey Of Radiation Oncologists And Urologists On Prediction Tools And Nomograms For Localized Prostate Cancer The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000556260.17883.48  0.369
2019 Mahal AR, Mahal BA, Kim S, Singh R, Green A, Nguyen PL, Gross CP, Yu JB. The Effect of Race and Decision Aids on Provider Recommendation for Prostate Cancer Treatment Planning: A Randomized Study International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.306  0.379
2018 Khanna A, Yerram N, Zhu H, Kim S, Abouassaly R. "Utilization of BCG for Non-Muscle Invasive Bladder Cancer in an Era of BCG Supply Shortages". Urology. PMID 30219556 DOI: 10.1016/J.Urology.2018.07.055  0.32
2018 Pacyna JE, Kim S, Yost K, Sedlacek H, Petereit D, Kaur J, Rapkin B, Grubb R, Paskett E, Chang GJ, Sloan J, Basch E, Major B, Novotny P, Taylor J, et al. The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD. Bmc Cancer. 18: 788. PMID 30081846 DOI: 10.1186/S12885-018-4672-3  0.375
2018 Kosarek C, Jazzar U, Shan Y, Klaassen Z, Huo J, Esparza E, Mehta H, Kuo Y, Kim S, Tyler D, Freedland S, Kamat A, Wolf D, Williams S. PD11-01 IMPACT OF POST-TREATMENT PSYCHIATRIC ILLNESS ON SURVIVAL OUTCOMES FOLLOWING TREATMENT FOR PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.624  0.357
2018 Kim S, Karnes J, Bukavina L, Houten HV, Gross C, Mwangi R, Shah N. Mp12-15 National Trends In The Management Of Localized Prostate Cancer From A Population-Based Cohort Of Privately Insured Patients The Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.402  0.401
2017 Lawson K, Saarela O, Abouassaly R, Kim S, Breau R, Finelli A. Mp22-06 The Impact Of Quality Variation On Patients Undergoing Surgery For Renal Cell Carcinoma: A National Cancer Database Study The Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.660  0.35
2017 Scarberry K, Scarberry K, Abouassaly R, Gonzalez C, Gross C, Shah N, Meropol N, Psutka S, Prasad S, Bukavina L, Kim S. Pd09-02 Racial Variation In The Refusal Of Initial Treatment Plan Among Men Diagnosed With Localized Prostate Cancer The Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.552  0.386
2017 Francis J, Kim S, Zhu H, Abouassaly R. Mp97-19 Surgical Outcomes In The Management Of High Risk Prostate Cancer Using The Surgical Outcomes For Advanced Prostate Cancer Score The Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.3063  0.403
2017 Hamada A, Kim S, Zhu H, Abouassaly R. Mp53-17 Current Management Of Prostate Cancer With Node-Positive Disease After Radical Prostatectomy And Its Impact On Overall Survival The Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.1668  0.385
2017 Fang JE, Huo J, Kerr P, Dafashy T, Ghaffary C, Ynalvez L, Baillargeon JG, Morales E, Kim S, O'Malley P, Kuo Y, Orihuela E, Tyler DS, Freedland SJ, Kamat AM, et al. Mp04-14 Survival Differences Among Bladder Cancer Patients According To Gender: Critical Evaluation Of Radical Cystectomy Use And Delay To Treatment The Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.152  0.377
2017 Ghaffary C, Duan Z, Chapin B, Dafashy T, Kosareck C, Chamie K, Kim S, Ahlering T, Davis J, Giordano S, Williams S. Mp47-12 Impact Of Proximity To Nci- And Nccn-Designated Cancer Centers On Outcomes For Patients With Prostate Cancer Undergoing Radical Prostatectomy The Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.1472  0.427
2016 Carroll PR, Parsons JK, Andriole G, Bahnson RR, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Farrington T, Hemstreet GP, Kawachi MH, Kim S, Lange PH, et al. NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016. Journal of the National Comprehensive Cancer Network : Jnccn. 14: 509-19. PMID 27160230 DOI: 10.6004/Jnccn.2016.0060  0.384
2016 Matthew B, Abouassaly R, Smaldone M, Kutikov A, Shah N, Boorjian S, Thompson RH, Gonzalez C, Zhu H, Kim S. Pd29-04 National Utilization Of Retroperitoneal Lymph Node Dissection Among Patients With Kidney Cancer And Clinical Lymphadenopathy Undergoing Nephrectomy The Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.522  0.335
2016 Matthew B, Maurice M, Kim S, Zhu H, Abouassaly R. Pd27-05 Increased Cystectomy Utilization In The Very Elderly Without Compromising Perioperative Outcomes: Results From The National Cancer Data Base The Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.379  0.332
2016 Patel A, Kim S, Maurice M, Kiechle J, Zhu H, Abouassaly R. Mp81-11 The Effect Of Sociodemographic Factors On The Management Of Stage I Non-Seminomatous Germ Cell Testicular Tumors The Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2064  0.334
2016 Ristau B, Handorf E, Uzzo R, Cahn D, Kim S, Haifler M, Waingankar N, Haseebuddin M, Viterbo R, Chen D, Greenberg R, Kutikov A, Smaldone M. Pd41-11 Differences In Overall Survival For Patients With Stage I-Ii Renal Cell Carcinoma Treated With Partial Or Radical Nephrectomy The Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.1557  0.31
2016 Matthew B, Maurice M, Kim S, Zhu H, Abouassaly R. Mp38-10 Cystectomy Associated With Improved Overall Survival In Very Elderly Patients With Muscle Invasive Bladder Cancer; Results From The National Cancer Data Base The Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.114  0.382
2015 Abdollah F, Sammon J, Sood A, Pucheril D, Klett D, Sun M, Aizer A, Choueiri T, Hu J, Kim S, Kibel A, Nguyen P, Menon M, Trinh Q. Mp73-11 Androgen Deprivation Therapy And Increased Non-Cancer Mortality In Prostate Cancer Patients: Analysis Of The Number Needed To Treat The Journal of Urology. 14. DOI: 10.1016/J.Juro.2015.02.2687  0.413
2015 Kim S, Karnes RJ, Gross C, Houten HV, Abouassaly R, Shah N. Pd44-05 Contemporary National Trends Of Prostate Cancer Screening Among Privately Insured Patients In The United States The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2551  0.38
2015 Haseebuddin M, Handorf E, Wong Y, Kim S, Wainganker N, Kutikov A, Bekelman J, Uzzo R, Smaldone M. Pd12-04 Trends In Utilization Of Primary Androgen Deprivation Therapy For Localized Prostate Cancer The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1056  0.384
2015 Lester-Coll NH, Park HSM, Rutter CE, Corso CD, Mancini BR, Yeboa DN, Kim S, Gross CP, Yu JB. Evaluation at Academic Centers Increases the Likelihood of Active Surveillance in Low-Risk Prostate Cancer International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.281  0.383
2014 Becker A, Ravi P, Roghmann F, Trinh QD, Tian Z, Larouche A, Kim S, Shariat SF, Kluth L, Dahlem R, Fisch M, Graefen M, Eichelberg C, Karakiewicz PI, Sun M. Laparoscopic radical nephrectomy vs laparoscopic or open partial nephrectomy for T1 renal cell carcinoma: comparison of complication rates in elderly patients during the initial phase of adoption. Urology. 83: 1285-91. PMID 24862392 DOI: 10.1016/J.Urology.2014.01.050  0.301
2014 Gandaglia G, Abdollah F, Hu J, Kim S, Briganti A, Sammon JD, Becker A, Roghmann F, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI, Trinh QD, Sun M. Is robot-assisted radical prostatectomy safe in men with high-risk prostate cancer? Assessment of perioperative outcomes, positive surgical margins, and use of additional cancer treatments. Journal of Endourology / Endourological Society. 28: 784-91. PMID 24499306 DOI: 10.1089/End.2013.0774  0.427
2014 Smaldone MC, Handorf E, Kim S, Thompson RH, Costello BA, Corcoran A, Wong Y, Uzzo RG, Leibovich BC, Kutikov A, Boorjian SA. Temporal trends and factors associated with receipt of systemic therapy among patients undergoing cytoreductive nephrectomy. Journal of Clinical Oncology. 32: 503-503. DOI: 10.1200/Jco.2014.32.4_Suppl.503  0.316
2014 Smaldone MC, Egleston B, Kim S, Handorf E, Geynisman DM, Wong Y, Uzzo RG, Kutikov A. Does nonsurgical management for localized kidney cancer equate to active surveillance in the SEER-Medicare population? Journal of Clinical Oncology. 32: 444-444. DOI: 10.1200/Jco.2014.32.4_Suppl.444  0.387
2014 Smaldone MC, Egleston B, Hollingsworth JM, Hollenbeck BK, Miller DC, Kim S, Handorf E, Wong Y, Uzzo RG, Kutikov A. Understanding treatment disconnect and mortality trends in renal cell carcinoma using tumor registry data. Journal of Clinical Oncology. 32: 403-403. DOI: 10.1200/Jco.2014.32.4_Suppl.403  0.309
2014 Delpe SD, Shah N, Tilburt JC, Karnes RJ, Nguyen PL, Shuch B, Gross C, Schulam P, Yu JB, Ziegenfuss J, Kim S. Perceptions of radiation oncologists and urologists on the type of evidence that informs and changes the clinical practice of prostate cancer. Journal of Clinical Oncology. 32: 167-167. DOI: 10.1200/Jco.2014.32.4_Suppl.167  0.401
2013 Ferwana M, Firwana B, Hasan R, Al-Mallah MH, Kim S, Montori VM, Murad MH. Pioglitazone and risk of bladder cancer: a meta-analysis of controlled studies. Diabetic Medicine : a Journal of the British Diabetic Association. 30: 1026-32. PMID 23350856 DOI: 10.1111/Dme.12144  0.361
2012 Zarei S, Frank I, Boorjian SA, Thompson RH, Kim S, Weight C, Tarrell R, Thapa P, Cheville JC. Prognostic significance of measured depth of invasion of urothelial carcinoma of the bladder compared to the 2010 American Joint Committee on Cancer pT2 and pT3 classifications. The Journal of Urology. 188: 1706-11. PMID 22998911 DOI: 10.1016/J.Juro.2012.07.035  0.321
2006 Kim S, Rosevear HM, Dunn RL, Hembroff L, Holmes-Rovner M, Rovner D, Taub DA, Fagerlin A, Wei JT. 221: Sociodemographic Variation in the use of Information Among Prostate Cancer Patients The Journal of Urology. 175: 73-73. DOI: 10.1016/S0022-5347(18)32488-1  0.395
Show low-probability matches.